Authors: Miller, MD Margot, NA Lamy, PD Fuller, MD Anton, KE Mulato, AS Cherrington, JM

Citation: Md. Miller et al., Adefovir and tenofovir susceptibilities of HIV-1 after 24 to 48 weeks of adefovir dipivoxil therapy: Genotypic and phenotypic analyses of study GS-96-408, J ACQ IMM D, 27(5), 2001, pp. 450-458

Authors: Robert, CM Exon, NF Kennett, JP Malone, MJ Brinkhuis, H Chaproniere, GCH Ennyu, A Fothergill, P Fuller, MD Grauert, M Hill, PJ Janecek, TR Kelly, DC Latimer, JC Roessig, KM Nees, S Ninnemann, US Nurnberg, D Pekar, SF Pellaton, CC Pfuhl, HA Rohl, U Schellenberg, SA Shevenell, AE Stickley, CE Suzuki, N Touchard, Y Wei, WC White, TS

Citation: Cm. Robert et al., Palaeogene ocean opening south of Tasmania, and palaeoceanographic implications: preliminary results of clay mineral analyses (ODP Leg 189)., CR AC S IIA, 332(5), 2001, pp. 323-329

Authors: Cihlar, T Lin, DC Pritchard, JB Fuller, MD Mendel, DB Sweet, DH

Citation: T. Cihlar et al., The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1, MOLEC PHARM, 56(3), 1999, pp. 570-580

Authors: Cherrington, JM Fuller, MD Lamy, PD Miner, R Lalezari, JP Nuessle, S Drew, WL

Citation: Jm. Cherrington et al., In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: Relationship to clinical outcome, J INFEC DIS, 178(6), 1998, pp. 1821-1825